(2R,4S,5S,7S)-5-amino-N-butyl-4-hydroxy-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-2,8-dimethylnonanamide

ID: ALA562634

Chembl Id: CHEMBL562634

PubChem CID: 9982638

Max Phase: Preclinical

Molecular Formula: C27H48N2O5

Molecular Weight: 480.69

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCNC(=O)[C@H](C)C[C@H](O)[C@@H](N)C[C@H](Cc1ccc(OC)c(OCCCOC)c1)C(C)C

Standard InChI:  InChI=1S/C27H48N2O5/c1-7-8-12-29-27(31)20(4)15-24(30)23(28)18-22(19(2)3)16-21-10-11-25(33-6)26(17-21)34-14-9-13-32-5/h10-11,17,19-20,22-24,30H,7-9,12-16,18,28H2,1-6H3,(H,29,31)/t20-,22+,23+,24+/m1/s1

Standard InChI Key:  HMXUWQWZWZLSAO-KAMZKSLDSA-N

Associated Targets(Human)

REN Tclin Renin (5251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

REN Renin (103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSD Cathepsin D (510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 480.69Molecular Weight (Monoisotopic): 480.3563AlogP: 3.95#Rotatable Bonds: 18
Polar Surface Area: 103.04Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.57CX LogP: 3.71CX LogD: 1.59
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.28Np Likeness Score: 0.22

References

1. Yamaguchi Y, Menear K, Cohen NC, Mah R, Cumin F, Schnell C, Wood JM, Maibaum J..  (2009)  The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.,  19  (16): [PMID:19615901] [10.1016/j.bmcl.2009.05.128]
2. Webb RL, Schiering N, Sedrani R, Maibaum J..  (2010)  Direct renin inhibitors as a new therapy for hypertension.,  53  (21): [PMID:20731374] [10.1021/jm901885s]

Source